Tagged With NASH

Drugmaker Madrigal just came out with some promising data for its treatment of NASH, a 'silent disease' millions are living with -- and the stock is exploding


There could be a $35 billion market to treat NASH, a 'silent disease' millions are living with -- and the competition's starting to heat up


Millions of people are living with a 'silent' disease they have likely never heard of



One of the next epidemic-level chronic diseases doesn't have any approved treatments -- and it could 'swamp the system'